1 unchanged sentence
Market and dividend information
−Removed: Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "MITT." As of February 17, 2023, there were 21,208,757 shares of common stock outstanding and approximately 37 registered holders of our common stock.
+Added: Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "MITT." As of March 6, 2024, there were 29,452,618 shares of common stock outstanding and approximately 45 registered holders of our common stock.
The 45 holders of record include Cede & Co., which holds shares as nominee for The Depository Trust Company, which itself holds shares on behalf of the beneficial owners of our common stock.
1 unchanged sentence
The following tables set forth, for the periods indicated, the high and low sale price of our common stock as reported on the NYSE and the dividends declared per share of our common stock.
−Removed: All per share amounts below have been adjusted to reflect the one-for-three reverse stock split effected July 22, 2021.
Year Ended December 31, 2023
12 unchanged sentences
10/24/2023 11/3/2023 11/8/2023 0.08 12/19/2022 12/30/2022 1/31/2023 0.18
+Added: 11/20/2023 11/30/2023 1/2/2024 0.05
+Added: 12/15/2023 12/29/2023 1/31/2024 0.05
Total $ 0.72 Total $ 0.81
4 unchanged sentences
Repurchase Program
−Removed: On August 3, 2022, the Company’s Board of Directors authorized a stock repurchase program to repurchase up to $15.0 million of the Company's outstanding common stock.
−Removed: The Board's authorization does not have an expiration date.
−Removed: The following table presents information related to our purchases of common stock pursuant to our stock repurchase program during the quarter ended December 31, 2022:
−Removed: Period (1) Total Number of Shares Purchased Weighted Average Price Paid per Share (2) Total Number of Shares Purchased as Part of Publicly Announced Program Maximum Approximate Dollar Value that May Yet Be Purchased Under the Program (2)
−Removed: October 1, 2022 to October 31, 2022 74,187 $ 4.32 74,187 $ 12,340,308
−Removed: November 1, 2022 to November 30, 2022 348,507 5.59 348,507 10,393,064
−Removed: December 1, 2022 to December 30, 2022 430,233 5.99 430,233 7,817,003
−Removed: Total 852,927 $ 5.68 852,927 $ 7,817,003
−Removed: (1) Based on trade date.
−Removed: (2) Includes brokerage commissions and clearing fees.
+Added: On August 3, 2022, our Board of Directors authorized a stock repurchase program (the “2022 Repurchase Program”) to repurchase up to $15.0 million of the our outstanding common stock.
+Added: The 2022 Repurchase Program does not have an expiration date.
+Added: As of December 31, 2023, approximately $1.5 million of common stock remained authorized for future share repurchases under the 2022 Repurchase Program.
+Added: On May 4, 2023, our Board of Directors authorized a stock repurchase program (the “2023 Repurchase Program”) to repurchase up to $15.0 million of the Company’s outstanding common stock on substantially the same terms as the 2022 Repurchase Program.
+Added: As of December 31, 2023, the full $15.0 million authorized amount remains available for repurchase under the 2023 Repurchase Program.
+Added: See Note 11 of the “Notes to Consolidated Financial Statements” for details on our purchases of common stock pursuant to our stock repurchase programs during year ended December 31, 2023.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.